Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles

Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles

We aimed to investigate which base was suitable for preparing transdermal formulations incorporating tulobuterol (TUL) nanoparticles (30–180 nm) in this study. Three bases (water-soluble, absorptive, and aqueous ionic cream) were selected to prepare the transdermal formulations, and TUL nanoparticle...

Full description

Bibliographic Details
Main Authors: Noriaki Nagai, Fumihiko Ogata, Saori Deguchi, Aoi Fushiki, Saki Daimyo, Hiroko Otake, Naohito Kawasaki
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
tulobuterol
nanoparticle
ointment
transdermal delivery system
endocytosis
Online Access:https://www.mdpi.com/1999-4923/14/11/2431

Internet

https://www.mdpi.com/1999-4923/14/11/2431

Similar Items